ARTPred

ARTPred (ReceptIVFity) is a legitimate, CE-IVD certified medical device offering microbiome profiling to improve IVF outcomes. External verification confirms clinical trials, hospital partnerships (e.g., Erasmus MC), and scientific publications. However, the project submission itself was of very low quality, containing demonstrably false claims (e.g., 'most people have used my product' and 'audience reach: everyone'). While the technology is innovative and legally validated, the lack of accurate user data and the 10-year timeline with relatively low apparent valuation (€2.5M) suggests slow commercial scaling. The score reflects high technical utility heavily penalized by poor submission integrity and niche market limits.